What is the partnership?
The global healthcare company GSK joined forces with Save the Children in 2013 to help save a million lives by reducing the number of preventable deaths of children under five. The partnership supports work in 41 countries, with two multimillion-pound flagship programmes in the Democratic Republic of Congo and Kenya. These programmes tackle barriers to healthcare and provide a range of services targeted at improving newborn, maternal and child health.
What did the company do?
GSK’s 20% Reinvestment Initiative is a commitment to reinvest 20 per cent of the company’s profits in the world’s least developed countries to improve the health infrastructure. This funding allows Save the Children to deliver programmes in 14 countries.
GSK employees support the partnership through the voluntary fundraising programme Orange United, which includes 444 Orange United Ambassadors from 51 countries. In 2017, 40 GSK employees from 24 countries scaled Mount Kenya, the second-highest mountain in Africa, and raised more than £273,000 for the partnership. Total employee fundraising since the partnership was launched in 2013 is now more than £3m.
More than 100 GSK employees have worked with Save the Children across 32 countries through GSK's skill-based volunteer scheme, Pulse.
Why did it win?
From September 2016 to August 2017, 14,738 children in Kenya and 39,537 children in the DRC were reached though life-saving interventions by the partnership. To date, more than 2.6 million children have been reached by the partnership, 97,600 children have been fully immunised, about 187,800 children treated for malaria, pneumonia or diarrhoea, and more than 16,000 health workers have been trained.
The combined expertise of the partnership has resulted in the development of a gel to prevent neonatal sepsis, a major cause of new-born death, which has benefited new-borns in Kenya.
Novo Nordisk with Diabetes UK
Simplyhealth with the Royal Voluntary Service